BioSpace.com Featured News

Johnson & Johnson: We're Creaming Medivation, Inc., Boehringer Ingelheim Corporation, Bristol-Myers Squibb Company and Pfizer Inc.

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Im at Johnson & Johnsons Pharmaceutical Business Review today. Most of the day is dedicated to geeky drug R&D stuff, but Joaquin Duato started of the morning with a run-down of how J&Js pharmaceutical division...

Social Media Suggests an MS Dogfight Between Biogen, Inc. and Novartis AG

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Over the past month, surveying the track record for the newly launched Tecfidera multiple sclerosis pill has become a closely watched exercise on Wall Street. Each week, analysts pore over prescription data...

Alex Denner Joins VIVUS, Inc. Activist Slate in Post-Icahn Move

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Alex Denner, the former head of health-care investments for billionaire Carl Icahn, joined the activist slate challenging drugmaker Vivus Inc. (VVUS) in the first move of his new fund, Sarissa Capital Management...

Astellas Pharma Inc. and Medivation, Inc. Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TOKYO & SAN FRANCISCO--(BUSINESS WIRE)--Astellas Pharma Inc. (TOKYO: 4503) and Medivation, Inc. (NASDAQ: MDVN) today announced that Astellas has submitted an application for marketing approval of enzalutamide...

Elixir Medical Announces Outstanding Two-Year Results From the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne® BD System With Biodegradable Polymer Coating

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today excellent long-term results...

Sangamo BioSciences, Inc. Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine to Develop ZFP Therapeutic® for Beta-thalassemia

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RICHMOND, Calif., May 24, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted...

Cardinal Health, Inc. Selects for Healthcare Data Discovery

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN MATEO, Calif., May 23, 2013 /PRNewswire/ -- Datameer announced today that Cardinal Health has selected the company...

Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.

Fri, 24 May 2013 12:00:00 AM GMT

1) NEWSLETTERStaying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAYWARD, Calif., May 24, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the...

CardioKinetix Inc. Announces Successful Parachute Live Case Transmission at 2013 Conference

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced the transmission of a live satellite feed of a clinical case using the first-of-its-kind...

Hansen Medical to Exhibit Magellan™ Robotic System at 2013 Vascular Annual Meeting® of the

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, CA--(Marketwired - May 23, 2013) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular...

Theravance, Inc. to Present at Investor Conferences in June 2013

Fri, 24 May 2013 12:00:00 AM GMT

SOUTH SAN FRANCISCO, CA--(Marketwired - May 23, 2013) - Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at the following investor conferences in June 2013:

Jefferies 2013 Global Healthcare Conference
Grand...

Anacor Pharmaceuticals, Inc. to Present at Deutsche Bank's 38th Annual Healthcare Conference

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the companys Chief Executive Officer, will provide a company overview at Deutsche Banks 38th Annual Healthcare Conference on Thursday...

IMPAX Laboratories, Inc. to Present at the Deutsche Bank 38th Annual Health Care Conference

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Deutsche Bank 38th Annual Health Care Conference on Thursday, May 30, at 12:00 p.m. Eastern Standard Time. The conference...

Agea Medical Has Its Sights on an $8 Million Offering

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Agea Medical is $2 million shy of its $8 million funding round goal. Officials at Agea Medical said it is closing in on an $8 million funding round. The Redwood City, Calif.-based medical device company has...

MS Patients Choose Death Risk With Biogen Idec, Inc. (Massachusetts)'s Potent Drug Treatment

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Kari Antin, a 40-year-old financial analyst in Minneapolis, knows shes taking a life-or-death risk with every monthly infusion of Biogen (BIIB) Idec Inc.s Tysabri. She is among the 55 percent of multiple...

How Scripted Aegerion Pharmaceuticals, Inc.'s Success Story

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

When Marc Beer sold his ?rst public company, the biotech ViaCell, to PerkinElmer for $300 million in 2007 it seemed like the beginning of an amazing entrepreneurial career. But just months later it was cut...

Universal Flu Jab "Edges Closer," Nature Study

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A way of creating more effective vaccines which could protect against a broad range of flu viruses has been reported by US researchers. A different seasonal flu jab is produced every year as the virus is a...

Jennerex, Inc. Completes $21.6 Million Private Placement

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Jennerex Completes $21.6 Million Private Placement

SAN FRANCISCO, CA--(Marketwired - May 23, 2013) - Jennerex Biotherapeutics, Inc., a...

Virobay Inc. Initiates a Phase 1 Trial of VBY-036, a Compound Intended for the Treatment of Neuropathic Pain

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif., May 23, 2013 /PRNewswire/ -- Virobay, Inc. today announced that their development of an oral treatment...

Kona Medical Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BELLEVUE, Wash. & MENLO PARK, Calif.--(BUSINESS WIRE)--Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR...

Portola Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, CA--(Marketwired - May 22, 2013) - Portola Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 8,422,758 shares of its common...

BioTime Announces Results of Vote at Special Meeting of Shareholders

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that at a Special Meeting held on May 21, 2013, its shareholders approved the proposals related to the planned acquisition of stem...

Oculus Innovative Sciences, Inc. Announces Fiscal Fourth Quarter 2013 Financial Results and Conference Call

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PETALUMA, Calif., May 23, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal fourth quarter 2013, ended March 31, 2013, will be...

Amyris, Inc. to Participate at the Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, announced today that the Company will participate in a renewable biomaterials...

Accuracy to Present at 2013 Jefferies and Co. Global Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SUNNYVALE, Calif., May 22, 2013 /PRNewswire/ -- Accuray Incorporated...

Konan Medical USA Inc. Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at Meeting in Paris

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR in Paris by Robert Whitbourn, MD, of St. Vincents Hospital...

The Logic of Biologics - Is Regeneron Pharmaceuticals, Inc. the Next Genentech?

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

When the US biotech company Regeneron Pharmaceuticals recently announced its first-quarter results, few were surprised that the companys flagship wet age-related macular degeneration (AMD) product Eylea...

European Medicines Agency Validates Gilead Sciences, Inc.'s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the companys Marketing Authorisation Application (MAA) for sofosbuvir, a once-daily oral nucleotide analogue inhibitor...

Wealthy Economic Liberals Actually are Wimps, University of California, Santa Cruz (UCSC) and Aarhus University Study

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A new study in the journal Psychological Science took a look at the relationship between physical strength and political beliefs. More specifically, the study sought to answer a question: is there any correlation...

Rigel Pharmaceuticals, Inc.'s R348 to Initiate Phase 2 Clinical Trial in Dry Eye

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., May 22, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced...

Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PALO ALTO, Calif., May 22, 2013 /PRNewswire/ -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has...

Studies at Annual Meeting Highlight Benefits of DFine StabiliT® Vertebral Augmentation System for the Treatment of Vertebral Compression Fractures (VCFs)

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced results from three studies...

CardioKinetix Inc. Announces Positive Clinical Data Showing Consistent Compelling Positive Results for Patients Treated With Minimally Invasive Structural Heart Device for Heart Failure

Wed, 22 May 2013 12:00:00 AM GMT

PARIS & MENLO PARK, Calif.--(BUSINESS WIRE)--CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device. Six-month clinical results from 91 U.S. and European patients with ischemic heart failure were presented at the 2013 EuroPCR...

Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S's Abilify Maintena in Schizophrenia

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Otsuka Pharmaceutical and Lundbeck: Study Shows Effects of Treatment with ABILIFY MAINTENA (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia1...

Accuray Inc. Release: New Data Validates CyberKnife SBRT for Prostate Cancer Treatment

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SUNNYVALE, Calif., May 21, 2013 /PRNewswire/ -- Accuray Incorporated...

Neuronetics, Inc. Release: New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients With Depression using NeuroStar TMS Therapy System

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, May 21, 2013 /PRNewswire/ -- New data released today at the annual meeting of the American Psychiatric...

Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif., May 21, 2013 /PRNewswire/ -- Cephasonics, a technology-innovation leader...

Clinovo Launches TechTrainings on CDISC Standards

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sunnyvale, CA. May 06, 2013. Clinovo's new CDISC Standards: Theory and Application class is an 8-week training program starting on June 11th, 2013. The TechTrainings are technical hands-on classes designed...

RenovoRx Named Winner of 2013 TiE50 "Top Startup"

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN JOSE, Calif., May 21, 2013 /PRNewswire/ -- RenovoRx (www.renovorx.com) has...

VIVUS, Inc. Announces Scientific Presentations

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity...

Auxogyn, Inc. Selected to Present at in Stockholm

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Menlo Park, CA May 22 2013 Auxogyn, Inc., a company focused on revolutionizing the field of reproductive medicine by providing novel scientific and clinically validated solutions to IVF clinicians and their...

Non-Wetting Fabric Drains Sweat, University of California, Davis (UCD) Study

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Waterproof fabrics that whisk away sweat could be the latest application of microfluidic technology developed by bioengineers at the University of California, Davis. The new fabric works like human skin, forming...

Grifols Signs Deal to License Aradigm Corporation's Pulmaquin for Up to $90.7 Million

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin

BARCELONA, Spain & HAYWARD, Calif.--(BUSINESS...

XenoPort, Inc. Drops Multiple Sclerosis Drug After Trial Failure

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif., May 20, 2013 (BUSINESS WIRE) -- XenoPort, Inc. XNPT 4.33% announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil (AP) for the treatment of patients...

IMPAX Laboratories, Inc. Board Steps in to Oversee Hayward Manufacturing Issues

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAYWARD, Calif. -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that its Board of Directors has established a Compliance Committee composed of three independent directors to provide oversight for...

AcelRx Pharmaceuticals Drug Device Meets Main Goal of Late-Stage Study

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain

REDWOOD CITY...

Jennerex, Inc. Announces Completion of Enrollment in Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, CA--(Marketwired - May 21, 2013) - Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization...

ChemoCentryx, Inc. Announces Phase I Data With CCX507, Company's New Generation Orally Administered CCR9 Inhibitor

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif. and ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI) announced data showing that CCX507, a next generation orally available inhibitor of the chemokine receptor...

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S: Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced results from a preliminary analysis that showed statistically significant reductions ...

Elixir Medical Announces Excellent Six-Month Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System at Late Breaking Clinical Trial Session of

Tue, 21 May 2013 12:00:00 AM GMT

CardioDx, Inc. Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus® CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PALO ALTO, Calif., May 20, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of

Benvenue Medical Completes Follow-Up Phase in KAST Study Evaluating Kiva® VCF Treatment System vs. Balloon Kyphoplasty

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif., May 21, 2013 /PRNewswire/ -- Benvenue...

KineMed, Inc. Announces an Agreement With MedImmune to Study Protein Dynamics Related to Neurodegenerative Diseases

Tue, 21 May 2013 12:00:00 AM GMT

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed Inc. (www.kinemed.com) today announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to study how a monoclonal antibody affects the dynamics of the cellular prion protein (PrPc).

Help employers find you! Check out all the

Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the...

Agilent Technologies, Inc. (Santa Clara, California) Introduces OpenLAB Data Store for Mass Spectrometry

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced OpenLAB Data Store for MS, a simple and affordable networked solution for compliant storage of mass spectral data acquired...

Abaxis, Inc. to Present at the Annual Dental & Veterinary Conference

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

UNION CITY, Calif., May 21, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing...

Cordis Corporation Showcases Cardiovascular Innovations at

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cordis Corporation, a global leader in innovative technology for cardiovascular interventions, will introduce the two latest additions to its portfolio of cardiovascular solutions at EuroPCR 2013, 21-24 May...

Genomic Health, Inc. Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ --

FDA Pins Abbott Diabetes Care's FreeStyle InsuLinx Blood Glucose Meters With Class 1